These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 8778747)

  • 21. The putatively antipsychotic agent amperozide produces behavioural stimulation in the rat. A behavioural and biochemical characterization.
    Waters N; Pettersson G; Carlsson A; Svensson K
    Naunyn Schmiedebergs Arch Pharmacol; 1989 Aug; 340(2):161-9. PubMed ID: 2572972
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Influence of repeated treatment with buspirone on central 5-hydroxytryptamine and dopamine synthesis.
    Tunnicliff G; Brokaw JJ; Hausz JA; Matheson GK; White GW
    Neuropharmacology; 1992 Oct; 31(10):991-5. PubMed ID: 1436392
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The atypical antipsychotic drug amperozide enhances rat cortical and striatal dopamine efflux.
    Pehek EA; Meltzer HY; Yamamoto BK
    Eur J Pharmacol; 1993 Aug; 240(1):107-9. PubMed ID: 8405119
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Acute flesinoxan treatment produces a different effect on rat brain serotonin synthesis than chronic treatment: an alpha-methyl-l-tryptophan autoradiographic study.
    Tohyama Y; Mück-Seler D; Diksic M
    Neurochem Int; 2007 Dec; 51(8):486-95. PubMed ID: 17574706
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Alcohol intake in high alcohol drinking (HAD) rats is suppressed by FG5865, a novel 5-HT1A agonist/5-HT2 antagonist.
    Long TA; Kalmus GW; Björk A; Myers RD
    Pharmacol Biochem Behav; 1996 Jan; 53(1):33-40. PubMed ID: 8848457
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Amperozide influences feeding independently of 5-HT2A receptor antagonism.
    Price IV; Gorzalka BB; White SJ; Arkinstall KH
    Neuropsychobiology; 1998; 37(3):155-9. PubMed ID: 9597673
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Behavioral and biochemical effects of amperozide and serotonin agents on nigrostriatal and mesolimbic dopamine systems.
    Chang PY; Chuang CH; Chen JC; Tung CS
    Chin J Physiol; 2008 Apr; 51(2):106-15. PubMed ID: 18666714
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Determination of the place conditioning and locomotor effects of amperozide in rats: a comparison with cocaine.
    Rademacher DJ; Anders KA; Riley MG; Nesbitt JT; Steinpreis RE
    Exp Clin Psychopharmacol; 2000 Aug; 8(3):434-43. PubMed ID: 10975635
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The mixed 5-HT 1A/2A receptor drug FG5938 suppresses alcohol drinking while enhancing feeding in P rats.
    Piercy KT; Björk AK; Myers RD
    Alcohol; 1996; 13(5):521-7. PubMed ID: 8888950
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The limbic functional selectivity of amperozide is not mediated by dopamine D2 receptors as assessed by in vitro and in vivo binding.
    Svartengren J; Celander M
    Eur J Pharmacol; 1994 Mar; 254(1-2):73-81. PubMed ID: 7911431
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Alcohol drinking in rats is attenuated by the mixed 5-HT1 agonist/5-HT2 antagonist FG 5893.
    Singh GK; Kalmus GW; Björk AK; Myers RD
    Alcohol; 1993; 10(3):243-8. PubMed ID: 8507395
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The cardiovascular effects of amperozide: interactions with cocaine.
    Jones EA; McMillen BA
    Pharmacol Toxicol; 1999 Feb; 84(2):53-8. PubMed ID: 10068147
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The effect of amperozide, a new antipsychotic drug, on plasma corticosterone concentration in the rat.
    Albinsson A; Andersson G
    Life Sci; 1992; 51(19):1535-44. PubMed ID: 1359366
    [TBL] [Abstract][Full Text] [Related]  

  • 34. 5-HT, dopamine, norepinephrine, and related metabolites in brain of low alcohol drinking (LAD) rats shift after chronic intra-hippocampal infusion of harman.
    Adell A; Myers RD
    Neurochem Res; 1995 Feb; 20(2):209-15. PubMed ID: 7540261
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evidence that 5-HT(2) Antagonism Elicits a 5-HT(3)-Mediated Increase in Dopamine Transmission.
    Wu WH; Huang NK; Tseng CJ; Yin TH; Tung CS
    J Biomed Sci; 1995 Apr; 2(2):174-182. PubMed ID: 11725054
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparative effects of continuous infusion of mCPP, Ro 60-0175 and d-fenfluramine on food intake, water intake, body weight and locomotor activity in rats.
    Vickers SP; Benwell KR; Porter RH; Bickerdike MJ; Kennett GA; Dourish CT
    Br J Pharmacol; 2000 Jul; 130(6):1305-14. PubMed ID: 10903970
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Alpha 2-autoreceptors and alpha 2-heteroreceptors modulating tyrosine and tryptophan hydroxylase activity in the rat brain in vivo: an investigation into the alpha 2-adrenoceptor subtypes.
    Esteban S; Lladó J; García-Sevilla JA
    Naunyn Schmiedebergs Arch Pharmacol; 1996 Mar; 353(4):391-9. PubMed ID: 8935705
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Risperidone: regional effects in vivo on release and metabolism of dopamine and serotonin in the rat brain.
    Hertel P; Nomikos GG; Iurlo M; Svensson TH
    Psychopharmacology (Berl); 1996 Mar; 124(1-2):74-86. PubMed ID: 8935802
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Amperozide, a putative anti-psychotic drug: uptake inhibition and release of dopamine in vitro in the rat brain.
    Eriksson E
    Life Sci; 1990; 47(23):2111-7. PubMed ID: 1979998
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Interaction of the novel antipsychotic drug amperozide and its metabolite FG5620 with central nervous system receptors and monoamine uptake sites: relation to behavioral and clinical effects.
    Svartengren J; Pettersson E; Björk A
    Biol Psychiatry; 1997 Aug; 42(4):247-59. PubMed ID: 9270901
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.